Disclosure of changes in executive officers and the proportion of female executives
First written in FY2019-Q3. . Latest entry: FY2025.
The whole theme swung hardest in 2022: 1 of 12 companies on the "Worse" side.
10 other companies' latest entry also says "Other".
- FY2025Changes in the executive composition and representative director structureAnnual report
「The company's board of directors consists of 6 men, including 1 outside director, and 3 women, including 2 outside directors. Women account for 33.3%.」
The board of directors changed from the previously disclosed 6 men and 4 women, with women accounting for 40.0%, to 6 men and 3 women, with women accounting for 33.3%. In addition, Koyanagi Noriko (小柳 典子) assumed office as Chairperson of the Board of Directors and Nishi Mikio (西 幹男) as Representative Director and President in June 2025. - FY2024Changes in the representative director structure and executive compositionAnnual report
「April 2024: Assumed office as Representative Director, Chairman and President (current)」
The disclosure states that an individual assumed office as Representative Director, Chairman and President. It also discloses that, after Director Miyazaki Issei (宮崎 一成) left office at the end of his term, the board of directors consisted of 6 men and 4 women, with women accounting for 40.0%. - FY2023Increase in the proportion of female executive officers and change in compositionAnnual report
「The company's board of directors consists of 6 men, including 1 outside director, and 4 women, including 3 outside directors. Women account for 40.0%.」
The executive composition became 6 men and 4 women, with women accounting for 40.0% of executive officers, up from the previously disclosed 33.3%. - FY2022Change in executive composition and increase in the proportion of female executive officersAnnual report
「6 men and 3 women (women accounted for 33.3% of officers).」
The executive composition became 6 men and 3 women, with women accounting for 33.3% of executive officers. This was an increase from the previous composition of 7 men and 3 women and a 30.0% proportion of women. - FY2021Change in executive composition and decline in the proportion of female executive officersAnnual report
「7 men and 3 women (women accounted for 30.0% of executive officers)」
The executive composition became 7 men and 3 women, with women accounting for 30.0% of executive officers, down from the previous fiscal year's 5 men and 4 women and 44.4% proportion of women. - FY2021-Q3Increase in the proportion of female executive officers following an executive officer's departureAnnual report
「Director, responsible for the Store Sales Department and Director, Fujii Akio (藤井 章夫), 15 December 2020 4 men and 4 women (women accounted for 50.0% of executive officers)」
After 1 director left office, the executive composition became 4 men and 4 women, with women accounting for 50.0% of executive officers. This was an increase from the 44.4% proportion of female executive officers disclosed for the previous fiscal year. - FY2020Lower Female Representation Among OfficersAnnual report
「5 men and 4 women (women accounted for 44.4% of executive officers)」
The proportion of female executive officers changed from 50.0% in the previous fiscal year to 44.4%. The disclosure states that there were 5 male and 4 female executive officers. - FY2019Higher Female Representation Among OfficersAnnual report
「4 men and 4 women (women accounted for 50.0% of executive officers)」
The executive composition changed from 5 men and 3 women, with women accounting for 37.5%, to 4 men and 4 women, with women accounting for 50.0%. - FY2019-Q3First statedAnnual report
「Director Responsible for the Life Science Research Institute and Director Shibata Hiroki (柴田 浩樹) 30 November 2018 Director Responsible for the General Affairs Department, Finance and Accounting Department, Operations Department, Information Development Department and Life Science Research Institute, and Director Miyazaki Issei (宮崎 一成) 1 December 2018 5 men and 3 women (women accounted for 37.5% of executive officers)」
The disclosure states that the director responsible for the Life Science Research Institute left office, the areas of responsibility of a director changed, and the executive composition was 5 men and 3 women, with women accounting for 37.5%.